Foundayo (Orforglipron) Foundayo is the new FDA-approved oral GLP-1 weight loss medication known for its day-long flexibility, with no food or water limitations
Enzmann Mehr als 50 Jahre klinische Erfahrung in der Mitochondrialen Medizin Dr
A 2025 meta-analysis of 33 placebo-controlled randomized trials involving nearly 6,000 participants found that GLP-1RAs modestly (but significantly) reduced LDL cholesterol and total cholesterol, and interestingly, weight change did not influence these lipid outcomes
People who Travel: Before traveling, many patients opt for Nutrient Injections to give their immune system a boost and help protect against illness while on the go
Reduced NGF is associated with Alzheimers disease, Parkinsons disease, and age-related cognitive decline
Start with transdermal estrogen to avoid the absorption issue entirely